Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase-A activity

Journal of Neurochemistry

Volumn 111, Issue 1, 2009, Pages 101-110

  Cao, Xia ^a   Rui, Lewei ^a   Pennington, Paul R ^a   Chlan Fourney, Jennifer ^a   Jiang, Zhongjian ^a   Wei, Zelan ^a   Li, Xin Min ^b   Edmondson, Dale E ^c   Mousseau, Darrell D ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Calcium; Depression; Mitochondrial permeability transition; Phosphorylation; Post translation

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; BRAIN CELL; BRAIN NERVE CELL; CATALYST; CELL LINE; CONSENSUS; DEPHOSPHORYLATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; OXIDATIVE STRESS; PHOSPHORYLATION; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; BENZIMIDAZOLES; CALCIUM; CARBOCYANINES; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CLORGYLINE; CONSENSUS SEQUENCE; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; FEMALE; HUMANS; IMIDAZOLES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 11; MONOAMINE OXIDASE; NEURONS; PHOSPHORYLATION; PREGNANCY; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SERINE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 70349214771     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06300.x     Document Type: Article

References (50)

1. Arnold J. R., Hysmith R. M. Boor P. J. (1990) The ultracytochemical demonstration of extramitochondrial monoamine oxidase activity. Biogenic Amines 7, 127 143.
2. Bianchi P., Kunduzova O., Masini E. et al. (2005) Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 112, 3297 3305.
3. 2 in vascular smooth muscle cells: potential involvement in vascular disease (review). Int. J. Mol. Med. 11, 229 234.
4. 2+, calmodulin, and protein kinase C in H2O2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells. Antioxid. Redox Signal. 6, 353 366.
5. Blunt B. C., Creek A. T., Henderson D. C. Hofmann P. A. (2007) H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytes. Am. J. Physiol. Heart Circ Physiol. 293, H1518 H1525.
6. Bortolato M., Chen K. Shih J. C. (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv. Drug Deliv. Rev. 60, 1527 1533.
7. Bulavin D. V., Higashimoto Y., Popoff I. J., Gaarde W. A., Basrur V., Potapova O., Appella E. Fornace A. J. Jr. (2001) Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411, 102 107.
8. Cao X., Wei Z., Gabriel G. G., Li X. Mousseau D. D. (2007) Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology. BMC Neurosci. 8, 73.
9. Chishti M. A., Yang D. S., Janus C. et al. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276, 21562 21570.
10. Coppen A. (1967) The biochemistry of affective disorders. Br. J. Psychiatry 113, 1237 1264.
11. Crack P. J., Cimdins K., Ali U., Hertzog P. J. Iannello R. C. (2006) Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons. J. Neural Transm. 113, 645 657.
12. Czerniczyniec A., Bustamante J. Lores-Arnaiz S. (2007) Improvement of mouse brain mitochondrial function after deprenyl treatment. Neuroscience 144, 685 693.
13. De Zutter G. S. Davis R. J. (2001) Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Proc. Natl Acad. Sci. USA 98, 6168 6173.
14. Emilsson L., Saetre P., Balciuniene J., Castensson A., Cairns N. Jazin E. E. (2002) Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients. Neurosci. Lett. 326, 56 60.
15. Fitzgerald J. C., Ufer C., De Girolamo L. A., Kuhn H. Billett E. E. (2007) Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells. J. Neurochem. 103, 2189 2199.
16. Fowler J. S., Alia-Klein N., Kriplani A. et al. (2007) Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol. Psychiatry 62, 355 358.
17. Franciosi S., Ryu J. K., Choi H. B., Radov L., Kim S. U. McLarnon J. G. (2006) Broad-spectrum effects of 4-aminopyridine to modulate amyloid beta1-42-induced cell signaling and functional responses in human microglia. J. Neurosci. 26, 11652 11664.
18. Geerlings M. I., den Heijer T., Koudstaal P. J., Hofman A. Breteler M. M. (2008) History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology 70, 1258 1264.
19. Gujrati V. R., Shanker K., Vrat S., Chandrawati Parmar S. S. (1996) Novel appearance of placental nuclear monoamine oxidase: biochemical and histochemical evidence for hyperserotonomic state in preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 175, 1543 1550.
20. Holt A. Baker G. B. (1996) Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine. Naunyn Schmiedebergs Arch. Pharmacol. 354, 17 24.
21. Jayakumar A. R., Panickar K. S., Murthy Ch R. Norenberg M. D. (2006) Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J. Neurosci. 26, 4774 4784.
22. Jenner P. Olanow C. W. (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47, S161 S170.
23. Jiang Y., Chen C., Li Z., Guo W., Gegner J. A., Lin S. Han J. (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J. Biol. Chem. 271, 17920 17926. (Pubitemid 26250772)
24. Konradi C., Riederer P. Youdim M. B. (1986) Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study. J. Neural Transm. Suppl. 22, 61 73.
25. Lee J. C., Laydon J. T., McDonnell P. C. et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739 746.
26. Lee S. H., Park J., Che Y., Han P. L. Lee J. K. (2000) Constitutive activity and differential localization of p38alpha and p38beta MAPKs in adult mouse brain. J. Neurosci. Res. 60, 623 631.
27. Ma J., Yoshimura M., Yamashita E., Nakagawa A., Ito A. Tsukihara T. (2004) Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J. Mol. Biol. 338, 103 114.
28. Maher P. Davis J. B. (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16, 6394 6401.
29. Malorni W., Giammarioli A. M., Matarrese P., Pietrangeli P., Agostinelli E., Ciaccio A., Grassilli E. Mondovi B. (1998) Protection against apoptosis by monoamine oxidase A inhibitors. FEBS Lett. 426, 155 159.
30. Maragos W. F., Young K. L., Altman C. S. et al. (2004) Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochem. Res. 29, 741 746.
31. Meyer J. H., Ginovart N., Boovariwala A. et al. (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch. Gen. Psychiatry 63, 1209 1216.
32. Miller J. R. Edmondson D. E. (1999) Influence of flavin analogue structure on the catalytic activities and flavinylation reactions of recombinant human liver monoamine oxidases A and B. J. Biol. Chem. 274, 23515 23525.
33. Miller A. H. Raison C. L. (2006) Cytokines, p38 MAP kinase and the pathophysiology of depression. Neuropsychopharmacology 31, 2089 2090.
34. Mousseau D. D., Baker G. B. Butterworth R. F. (1997) Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. J. Neurochem. 68, 1200 1208.
35. Nishimura A. L., Guindalini C., Oliveira J. R., Nitrini R., Bahia V. S., de Brito-Marques P. R., Otto P. A. Zatz M. (2005) Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimer's disease? J. Mol. Neurosci. 27, 213 217.
36. Ou X. M., Chen K. Shih J. C. (2006) Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc. Natl Acad. Sci. USA 103, 10923 10928.
37. Palop J. J., Jones B., Kekonius L., Chin J., Yu G. Q., Raber J., Masliah E. Mucke L. (2003) Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc. Natl Acad. Sci. USA 100, 9572 9577.
38. Porras A., Zuluaga S., Black E., Valladares A., Alvarez A. M., Ambrosino C., Benito M. Nebreda A. R. (2004) P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell 15, 922 933.
39. Rapp M. A., Schnaider-Beeri M., Grossman H. T., Sano M., Perl D. P., Purohit D. P., Gorman J. M. Haroutunian V. (2006) Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gen. Psychiatry 63, 161 167.
40. Sun A., Liu M., Nguyen X. V. Bing G. (2003) P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp. Neurol. 183, 394 405.
41. Takehashi M., Tanaka S., Masliah E. Ueda K. (2002) Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant. Neurosci. Lett. 327, 79 82.
42. Thibault O., Porter N. M., Chen K. C., Blalock E. M., Kaminker P. G., Clodfelter G. V., Brewer L. D. Landfield P. W. (1998) Calcium dysregulation in neuronal aging and Alzheimer's disease: history and new directions. Cell Calcium 24, 417 433.
43. Tsugeno Y. Ito A. (1997) A key amino acid responsible for substrate selectivity of monoamine oxidase A and B. J. Biol. Chem. 272, 14033 14036.
44. Upadhyay A. K. Edmondson D. E. (2009) Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B. Biochemistry 48, 3928 3935.
45. Upadhyay A. K., Borbat P. P., Wang J., Freed J. H. Edmondson D. E. (2008) Determination of the oligomeric states of human and rat monoamine oxidases in the outer mitochondrial membrane and octyl beta-D-glucopyranoside micelles using pulsed dipolar electron spin resonance spectroscopy. Biochemistry 47, 1554 1566.
46. Wang J., Harris J., Mousseau D. D. Edmondson D. E. (2009) Mutagenic probes of the role of Ser209 on the cavity shaping loop of human monoamine oxidase A. FEBS J. 276, 4569 4581.
47. Wu X. J., Zheng Y. J., Cui Y. Y., Zhu L., Lu Y. Chen H. Z. (2007) Propofol attenuates oxidative stress-induced PC12 cell injury via p38 MAP kinase dependent pathway. Acta Pharmacol. Sin. 28, 1123 1128.
48. Wysk M., Yang D. D., Lu H. T., Flavell R. A. Davis R. J. (1999) Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl Acad. Sci. USA 96, 3763 3768.
49. Youdim M. B., Edmondson D. Tipton K. F. (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 7, 295 309.
50. Zhu X., Raina A. K., Lee H. G., Chao M., Nunomura A., Tabaton M., Petersen R. B., Perry G. Smith M. A. (2003) Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. Antioxid. Redox Signal. 5, 571 576. (Pubitemid 37315144)